Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
giovanna.poce@uniroma1.it
Giovanna Poce
Professore Associato
Struttura:
DIPARTIMENTO DI CHIMICA E TECNOLOGIE DEL FARMACO
E-mail:
giovanna.poce@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Nano-Based Drug Delivery Systems of Potent MmpL3 Inhibitors for Tuberculosis Treatment
PHARMACEUTICS
2022
Malaria transmission blocking compounds: a patent review
EXPERT OPINION ON THERAPEUTIC PATENTS
2022
Nano-Based Drug Delivery Systems of Potent MmpL3 Inhibitors for Tuberculosis Treatment
PHARMACEUTICS
2022
Therapeutic potential for coxibs-nitric oxide releasing hybrids in cystic fibrosis
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
2021
6-Fluorophenylbenzohydrazides inhibit Mycobacterium tuberculosis growth through alteration of tryptophan biosynthesis
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
2021
A novel class of dual-acting DCH-CORMs counteracts oxidative stress-induced inflammation in human primary tenocytes
ANTIOXIDANTS
2021
Dietary flavonoids: Nano delivery and nanoparticles for cancer therapy
SEMINARS IN CANCER BIOLOGY
2020
Sar analysis of small molecules interfering with energy-metabolism in mycobacterium tuberculosis
PHARMACEUTICALS
2020
Overcoming drug resistance in TB: An update
FUTURE MICROBIOLOGY
2020
Novel therapies for glaucoma: a patent review (2013-2019)
EXPERT OPINION ON THERAPEUTIC PATENTS
2019
Mycobacterial tryptophan biosynthesis: a promising target for tuberculosis drug development?
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
2019
Novel pyrazole-containing compounds active against mycobacterium tuberculosis
ACS MEDICINAL CHEMISTRY LETTERS
2019
Chocolate consumers and lymphocyte-to-monocyte ratio: a working hypothesis from a preliminary report of a pilot study in celiac subjects
ANTIOXIDANTS
2019
Development of MmpL3 inhibitors for tuberculosis treatment
Medicinal Chemistry approaches to tuberculosis and trypanosomiasis
2019
In vivo potent BM635 analogue with improved drug-like properties
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
2018
Stimuli-responsive tannin–feIII hybrid microcapsules demonstrated by the active release of an anti-tuberculosis agent
CHEMSUSCHEM
2018
1,5-Diarylpyrroles as potent antitubercular and anti-inflammatory agents
CHEMISTRY OF HETEROCYCLIC COMPOUNDS
2017
MmpL3 is the flippase for mycolic acids in mycobacteria
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
2017
Pharmaceutical salt of BM635 with improved bioavailability
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
2017
Synthesis and biological evaluation of fluorinated 1,5-diarylpyrrole-3-alkoxyethyl ether derivatives as selective COX-2 inhibitors endowed with anti-inflammatory activity
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
2016
1
2
seguente ›
ultima »
Progetti di Ricerca
Nuovi derivati pirazolici come potenziali agenti anti-tubercolari
Nuovi derivati tri-antranilati come potenziali agenti anti-tubercolari
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma